nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Dactinomycin—sarcoma	0.161	0.289	CbGbCtD
Clofarabine—ABCG2—Mitoxantrone—sarcoma	0.144	0.259	CbGbCtD
Clofarabine—ABCG2—Vincristine—sarcoma	0.0994	0.178	CbGbCtD
Clofarabine—ABCG2—Etoposide—sarcoma	0.0911	0.163	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—sarcoma	0.0621	0.111	CbGbCtD
Clofarabine—RRM1—larynx—sarcoma	0.013	0.106	CbGeAlD
Clofarabine—POLA1—mammary gland—sarcoma	0.00532	0.0433	CbGeAlD
Clofarabine—RRM2—mammary gland—sarcoma	0.00508	0.0414	CbGeAlD
Clofarabine—Adenosine monophosphate—CREB1—sarcoma	0.00441	0.712	CrCbGaD
Clofarabine—RRM1—mammary gland—sarcoma	0.00422	0.0344	CbGeAlD
Clofarabine—POLA1—myometrium—sarcoma	0.00377	0.0307	CbGeAlD
Clofarabine—RRM2—myometrium—sarcoma	0.00361	0.0293	CbGeAlD
Clofarabine—RRM2—embryo—sarcoma	0.00347	0.0282	CbGeAlD
Clofarabine—POLA1—seminal vesicle—sarcoma	0.00341	0.0277	CbGeAlD
Clofarabine—POLA1—hematopoietic system—sarcoma	0.00324	0.0264	CbGeAlD
Clofarabine—RRM2—hematopoietic system—sarcoma	0.0031	0.0252	CbGeAlD
Clofarabine—RRM1—myometrium—sarcoma	0.00299	0.0244	CbGeAlD
Clofarabine—RRM2—Vinorelbine—Vincristine—sarcoma	0.00287	0.398	CbGdCrCtD
Clofarabine—POLA1—Vinblastine—Vincristine—sarcoma	0.00272	0.376	CbGdCrCtD
Clofarabine—RRM1—seminal vesicle—sarcoma	0.00271	0.022	CbGeAlD
Clofarabine—RRM2—skin of body—sarcoma	0.00269	0.0219	CbGeAlD
Clofarabine—RRM1—hematopoietic system—sarcoma	0.00257	0.0209	CbGeAlD
Clofarabine—RRM2—uterus—sarcoma	0.00234	0.019	CbGeAlD
Clofarabine—DCK—myometrium—sarcoma	0.00233	0.0189	CbGeAlD
Clofarabine—RRM1—smooth muscle tissue—sarcoma	0.00226	0.0184	CbGeAlD
Clofarabine—DCK—embryo—sarcoma	0.00224	0.0182	CbGeAlD
Clofarabine—RRM1—skin of body—sarcoma	0.00224	0.0182	CbGeAlD
Clofarabine—RRM2—lymphoid tissue—sarcoma	0.00218	0.0177	CbGeAlD
Clofarabine—POLA1—tendon—sarcoma	0.00214	0.0175	CbGeAlD
Clofarabine—DCK—seminal vesicle—sarcoma	0.0021	0.0171	CbGeAlD
Clofarabine—POLA1—bone marrow—sarcoma	0.00208	0.0169	CbGeAlD
Clofarabine—RRM2—tendon—sarcoma	0.00205	0.0167	CbGeAlD
Clofarabine—DCK—hematopoietic system—sarcoma	0.002	0.0163	CbGeAlD
Clofarabine—RRM2—bone marrow—sarcoma	0.00198	0.0162	CbGeAlD
Clofarabine—RRM1—cardiac atrium—sarcoma	0.00195	0.0159	CbGeAlD
Clofarabine—RRM1—uterus—sarcoma	0.00194	0.0158	CbGeAlD
Clofarabine—RRM1—lymphoid tissue—sarcoma	0.00181	0.0147	CbGeAlD
Clofarabine—Adenosine monophosphate—SRC—sarcoma	0.00178	0.288	CrCbGaD
Clofarabine—POLA1—testis—sarcoma	0.00178	0.0145	CbGeAlD
Clofarabine—RRM1—tendon—sarcoma	0.0017	0.0139	CbGeAlD
Clofarabine—RRM2—testis—sarcoma	0.0017	0.0138	CbGeAlD
Clofarabine—POLA1—liver—sarcoma	0.00168	0.0137	CbGeAlD
Clofarabine—RRM1—bone marrow—sarcoma	0.00165	0.0134	CbGeAlD
Clofarabine—RRM2—liver—sarcoma	0.0016	0.0131	CbGeAlD
Clofarabine—DCK—cardiac atrium—sarcoma	0.00152	0.0123	CbGeAlD
Clofarabine—DCK—uterus—sarcoma	0.00151	0.0123	CbGeAlD
Clofarabine—RRM1—testis—sarcoma	0.00141	0.0115	CbGeAlD
Clofarabine—DCK—lymphoid tissue—sarcoma	0.00141	0.0114	CbGeAlD
Clofarabine—RRM1—liver—sarcoma	0.00133	0.0108	CbGeAlD
Clofarabine—DCK—tendon—sarcoma	0.00132	0.0108	CbGeAlD
Clofarabine—ABCG2—myometrium—sarcoma	0.0013	0.0106	CbGeAlD
Clofarabine—POLA1—lymph node—sarcoma	0.00129	0.0105	CbGeAlD
Clofarabine—DCK—bone marrow—sarcoma	0.00128	0.0104	CbGeAlD
Clofarabine—RRM2—lymph node—sarcoma	0.00123	0.01	CbGeAlD
Clofarabine—ABCG2—seminal vesicle—sarcoma	0.00117	0.00954	CbGeAlD
Clofarabine—DCK—testis—sarcoma	0.00109	0.00891	CbGeAlD
Clofarabine—DCK—liver—sarcoma	0.00103	0.00842	CbGeAlD
Clofarabine—RRM1—lymph node—sarcoma	0.00102	0.00832	CbGeAlD
Clofarabine—DCK—Doxorubicin—Epirubicin—sarcoma	0.000849	0.118	CbGdCrCtD
Clofarabine—ABCG2—uterus—sarcoma	0.000842	0.00685	CbGeAlD
Clofarabine—DCK—lymph node—sarcoma	0.000793	0.00646	CbGeAlD
Clofarabine—DCK—Epirubicin—Doxorubicin—sarcoma	0.000785	0.109	CbGdCrCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000773	0.0781	CbGpPWpGaD
Clofarabine—ABCG2—bone marrow—sarcoma	0.000714	0.00582	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000637	0.0643	CbGpPWpGaD
Clofarabine—ABCG2—testis—sarcoma	0.000611	0.00497	CbGeAlD
Clofarabine—ABCG2—liver—sarcoma	0.000577	0.0047	CbGeAlD
Clofarabine—ABCG2—lymph node—sarcoma	0.000443	0.0036	CbGeAlD
Clofarabine—Paraesthesia—Mitoxantrone—sarcoma	0.000285	0.000966	CcSEcCtD
Clofarabine—Lethargy—Doxorubicin—sarcoma	0.000285	0.000964	CcSEcCtD
Clofarabine—Decreased appetite—Vincristine—sarcoma	0.000284	0.00096	CcSEcCtD
Clofarabine—Dyspnoea—Mitoxantrone—sarcoma	0.000283	0.000959	CcSEcCtD
Clofarabine—Cough—Etoposide—sarcoma	0.000283	0.000957	CcSEcCtD
Clofarabine—Somnolence—Mitoxantrone—sarcoma	0.000283	0.000956	CcSEcCtD
Clofarabine—Blood creatinine increased—Epirubicin—sarcoma	0.000282	0.000956	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Vincristine—sarcoma	0.000282	0.000954	CcSEcCtD
Clofarabine—Fatigue—Vincristine—sarcoma	0.000281	0.000952	CcSEcCtD
Clofarabine—Dehydration—Epirubicin—sarcoma	0.00028	0.000949	CcSEcCtD
Clofarabine—Hypertension—Etoposide—sarcoma	0.00028	0.000947	CcSEcCtD
Clofarabine—Pain—Vincristine—sarcoma	0.000279	0.000945	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000279	0.000944	CcSEcCtD
Clofarabine—Pain in extremity—Doxorubicin—sarcoma	0.000279	0.000944	CcSEcCtD
Clofarabine—Dry skin—Epirubicin—sarcoma	0.000276	0.000935	CcSEcCtD
Clofarabine—Decreased appetite—Mitoxantrone—sarcoma	0.000276	0.000935	CcSEcCtD
Clofarabine—Abdominal pain upper—Epirubicin—sarcoma	0.000275	0.000932	CcSEcCtD
Clofarabine—Fatigue—Mitoxantrone—sarcoma	0.000274	0.000927	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000274	0.000927	CcSEcCtD
Clofarabine—Pain—Mitoxantrone—sarcoma	0.000272	0.00092	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000272	0.000919	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000272	0.000919	CcSEcCtD
Clofarabine—Hypersensitivity—Thiotepa—sarcoma	0.000271	0.000918	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000271	0.0274	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—NPM1—sarcoma	0.00027	0.0272	CbGpPWpGaD
Clofarabine—Hypersensitivity—Dactinomycin—sarcoma	0.000269	0.000911	CcSEcCtD
Clofarabine—Gastrointestinal pain—Vincristine—sarcoma	0.000267	0.000903	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000266	0.0009	CcSEcCtD
Clofarabine—Asthenia—Thiotepa—sarcoma	0.000264	0.000894	CcSEcCtD
Clofarabine—Infection—Etoposide—sarcoma	0.000263	0.000889	CcSEcCtD
Clofarabine—Asthenia—Dactinomycin—sarcoma	0.000262	0.000887	CcSEcCtD
Clofarabine—POLA1—S Phase—STAG1—sarcoma	0.000262	0.0265	CbGpPWpGaD
Clofarabine—Feeling abnormal—Mitoxantrone—sarcoma	0.000262	0.000886	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—sarcoma	0.000261	0.000885	CcSEcCtD
Clofarabine—Influenza—Epirubicin—sarcoma	0.000261	0.000882	CcSEcCtD
Clofarabine—Pruritus—Thiotepa—sarcoma	0.00026	0.000881	CcSEcCtD
Clofarabine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00026	0.00088	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—sarcoma	0.000259	0.000878	CcSEcCtD
Clofarabine—Thrombocytopenia—Etoposide—sarcoma	0.000259	0.000876	CcSEcCtD
Clofarabine—Tachycardia—Etoposide—sarcoma	0.000258	0.000873	CcSEcCtD
Clofarabine—Abdominal pain—Vincristine—sarcoma	0.000258	0.000873	CcSEcCtD
Clofarabine—Body temperature increased—Vincristine—sarcoma	0.000258	0.000873	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000257	0.026	CbGpPWpGaD
Clofarabine—Skin disorder—Etoposide—sarcoma	0.000257	0.000869	CcSEcCtD
Clofarabine—Dry skin—Doxorubicin—sarcoma	0.000256	0.000866	CcSEcCtD
Clofarabine—Hyperhidrosis—Etoposide—sarcoma	0.000256	0.000865	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—sarcoma	0.000256	0.000865	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—sarcoma	0.000255	0.000862	CcSEcCtD
Clofarabine—Anorexia—Etoposide—sarcoma	0.000252	0.000853	CcSEcCtD
Clofarabine—Diarrhoea—Thiotepa—sarcoma	0.000252	0.000852	CcSEcCtD
Clofarabine—Body temperature increased—Mitoxantrone—sarcoma	0.000251	0.00085	CcSEcCtD
Clofarabine—Abdominal pain—Mitoxantrone—sarcoma	0.000251	0.00085	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000251	0.00085	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000251	0.00085	CcSEcCtD
Clofarabine—Diarrhoea—Dactinomycin—sarcoma	0.00025	0.000846	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—sarcoma	0.000247	0.000838	CcSEcCtD
Clofarabine—Hypotension—Etoposide—sarcoma	0.000247	0.000836	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000246	0.000833	CcSEcCtD
Clofarabine—Neutropenia—Epirubicin—sarcoma	0.000244	0.000825	CcSEcCtD
Clofarabine—Dizziness—Thiotepa—sarcoma	0.000243	0.000824	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000242	0.00082	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—sarcoma	0.000241	0.000816	CcSEcCtD
Clofarabine—Hypersensitivity—Vincristine—sarcoma	0.00024	0.000814	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000238	0.024	CbGpPWpGaD
Clofarabine—Paraesthesia—Etoposide—sarcoma	0.000237	0.000803	CcSEcCtD
Clofarabine—Pancreatitis—Doxorubicin—sarcoma	0.000236	0.0008	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—sarcoma	0.000236	0.000798	CcSEcCtD
Clofarabine—Dyspnoea—Etoposide—sarcoma	0.000236	0.000798	CcSEcCtD
Clofarabine—Somnolence—Etoposide—sarcoma	0.000235	0.000795	CcSEcCtD
Clofarabine—Hypersensitivity—Mitoxantrone—sarcoma	0.000234	0.000793	CcSEcCtD
Clofarabine—Asthenia—Vincristine—sarcoma	0.000234	0.000793	CcSEcCtD
Clofarabine—Vomiting—Thiotepa—sarcoma	0.000234	0.000792	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—sarcoma	0.000234	0.000791	CcSEcCtD
Clofarabine—Infestation—Epirubicin—sarcoma	0.000232	0.000786	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—sarcoma	0.000232	0.000786	CcSEcCtD
Clofarabine—Vomiting—Dactinomycin—sarcoma	0.000232	0.000786	CcSEcCtD
Clofarabine—Rash—Thiotepa—sarcoma	0.000232	0.000785	CcSEcCtD
Clofarabine—Dermatitis—Thiotepa—sarcoma	0.000232	0.000785	CcSEcCtD
Clofarabine—Headache—Thiotepa—sarcoma	0.000231	0.00078	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00023	0.00078	CcSEcCtD
Clofarabine—Rash—Dactinomycin—sarcoma	0.00023	0.00078	CcSEcCtD
Clofarabine—Decreased appetite—Etoposide—sarcoma	0.00023	0.000778	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—sarcoma	0.000229	0.000775	CcSEcCtD
Clofarabine—Renal failure—Epirubicin—sarcoma	0.000228	0.000773	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Etoposide—sarcoma	0.000228	0.000773	CcSEcCtD
Clofarabine—Asthenia—Mitoxantrone—sarcoma	0.000228	0.000772	CcSEcCtD
Clofarabine—Fatigue—Etoposide—sarcoma	0.000228	0.000771	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—sarcoma	0.000228	0.000771	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—sarcoma	0.000226	0.000767	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—sarcoma	0.000226	0.000767	CcSEcCtD
Clofarabine—Pain—Etoposide—sarcoma	0.000226	0.000765	CcSEcCtD
Clofarabine—Neutropenia—Doxorubicin—sarcoma	0.000225	0.000763	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000224	0.000758	CcSEcCtD
Clofarabine—Diarrhoea—Vincristine—sarcoma	0.000223	0.000756	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—sarcoma	0.000222	0.00075	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—sarcoma	0.00022	0.000744	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—sarcoma	0.000219	0.000742	CcSEcCtD
Clofarabine—Nausea—Thiotepa—sarcoma	0.000219	0.00074	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—sarcoma	0.000218	0.000738	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—sarcoma	0.000218	0.000738	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—sarcoma	0.000218	0.000737	CcSEcCtD
Clofarabine—Diarrhoea—Mitoxantrone—sarcoma	0.000217	0.000736	CcSEcCtD
Clofarabine—Nausea—Dactinomycin—sarcoma	0.000217	0.000734	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—sarcoma	0.000216	0.000732	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—sarcoma	0.000216	0.000732	CcSEcCtD
Clofarabine—Dizziness—Vincristine—sarcoma	0.000216	0.00073	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—sarcoma	0.000215	0.000728	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—sarcoma	0.000215	0.000728	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000213	0.000721	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—sarcoma	0.000211	0.000715	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000211	0.000713	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—sarcoma	0.00021	0.00071	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—sarcoma	0.00021	0.000709	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—sarcoma	0.00021	0.000709	CcSEcCtD
Clofarabine—Abdominal pain—Etoposide—sarcoma	0.000209	0.000707	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—sarcoma	0.000209	0.000707	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—sarcoma	0.000209	0.000706	CcSEcCtD
Clofarabine—Vomiting—Vincristine—sarcoma	0.000208	0.000702	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—sarcoma	0.000206	0.000697	CcSEcCtD
Clofarabine—Rash—Vincristine—sarcoma	0.000206	0.000696	CcSEcCtD
Clofarabine—Dermatitis—Vincristine—sarcoma	0.000206	0.000696	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—sarcoma	0.000205	0.000695	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—sarcoma	0.000205	0.0207	CbGpPWpGaD
Clofarabine—Haematuria—Doxorubicin—sarcoma	0.000205	0.000694	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—sarcoma	0.000205	0.000694	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—sarcoma	0.000204	0.000692	CcSEcCtD
Clofarabine—Headache—Vincristine—sarcoma	0.000204	0.000692	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000203	0.000688	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—sarcoma	0.000203	0.000686	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000202	0.0204	CbGpPWpGaD
Clofarabine—Vomiting—Mitoxantrone—sarcoma	0.000202	0.000684	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—sarcoma	0.000202	0.000683	CcSEcCtD
Clofarabine—Rash—Mitoxantrone—sarcoma	0.0002	0.000678	CcSEcCtD
Clofarabine—Dermatitis—Mitoxantrone—sarcoma	0.0002	0.000678	CcSEcCtD
Clofarabine—Headache—Mitoxantrone—sarcoma	0.000199	0.000674	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—sarcoma	0.000197	0.000668	CcSEcCtD
Clofarabine—Hypersensitivity—Etoposide—sarcoma	0.000195	0.000659	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—sarcoma	0.000194	0.000657	CcSEcCtD
Clofarabine—Nausea—Vincristine—sarcoma	0.000194	0.000656	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—sarcoma	0.000194	0.000655	CcSEcCtD
Clofarabine—Flushing—Epirubicin—sarcoma	0.000194	0.000655	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—sarcoma	0.000193	0.000653	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000192	0.0194	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Doxorubicin—sarcoma	0.000191	0.000645	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—sarcoma	0.00019	0.000644	CcSEcCtD
Clofarabine—Asthenia—Etoposide—sarcoma	0.00019	0.000642	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—sarcoma	0.00019	0.000642	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—sarcoma	0.000189	0.000641	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—sarcoma	0.000189	0.00064	CcSEcCtD
Clofarabine—Nausea—Mitoxantrone—sarcoma	0.000189	0.000639	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—sarcoma	0.000188	0.000638	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—sarcoma	0.000188	0.000636	CcSEcCtD
Clofarabine—Chills—Epirubicin—sarcoma	0.000187	0.000633	CcSEcCtD
Clofarabine—Pruritus—Etoposide—sarcoma	0.000187	0.000633	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—sarcoma	0.000184	0.000624	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—sarcoma	0.000183	0.000619	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—sarcoma	0.000182	0.000618	CcSEcCtD
Clofarabine—Erythema—Epirubicin—sarcoma	0.000182	0.000615	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—sarcoma	0.000182	0.000615	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—sarcoma	0.000181	0.000612	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—sarcoma	0.000179	0.000606	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—sarcoma	0.000179	0.000606	CcSEcCtD
Clofarabine—Back pain—Epirubicin—sarcoma	0.000176	0.000594	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—sarcoma	0.000175	0.000593	CcSEcCtD
Clofarabine—Dizziness—Etoposide—sarcoma	0.000175	0.000592	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—sarcoma	0.000174	0.00059	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—sarcoma	0.000174	0.000589	CcSEcCtD
Clofarabine—Chills—Doxorubicin—sarcoma	0.000173	0.000586	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—sarcoma	0.000171	0.000577	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—sarcoma	0.000169	0.0171	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—sarcoma	0.000169	0.000572	CcSEcCtD
Clofarabine—Vomiting—Etoposide—sarcoma	0.000168	0.000569	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—sarcoma	0.000168	0.000569	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—sarcoma	0.000168	0.000569	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—sarcoma	0.000168	0.000568	CcSEcCtD
Clofarabine—Agitation—Epirubicin—sarcoma	0.000167	0.000565	CcSEcCtD
Clofarabine—Rash—Etoposide—sarcoma	0.000167	0.000564	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—sarcoma	0.000167	0.000564	CcSEcCtD
Clofarabine—Headache—Etoposide—sarcoma	0.000166	0.000561	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000165	0.0166	CbGpPWpGaD
Clofarabine—Leukopenia—Epirubicin—sarcoma	0.000163	0.00055	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—sarcoma	0.000163	0.00055	CcSEcCtD
Clofarabine—Cough—Epirubicin—sarcoma	0.000158	0.000536	CcSEcCtD
Clofarabine—Nausea—Etoposide—sarcoma	0.000157	0.000531	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—sarcoma	0.000157	0.000531	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—sarcoma	0.000155	0.000526	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—sarcoma	0.000155	0.000523	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—sarcoma	0.000155	0.000523	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—sarcoma	0.000154	0.000523	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—sarcoma	0.000154	0.000521	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000154	0.00052	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000153	0.0154	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—sarcoma	0.00015	0.000509	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	0.000148	0.015	CbGpPWpGaD
Clofarabine—Oedema—Epirubicin—sarcoma	0.000148	0.000502	CcSEcCtD
Clofarabine—Infection—Epirubicin—sarcoma	0.000147	0.000498	CcSEcCtD
Clofarabine—Cough—Doxorubicin—sarcoma	0.000147	0.000496	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—sarcoma	0.000145	0.000492	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—sarcoma	0.000145	0.000491	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—sarcoma	0.000145	0.000491	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—sarcoma	0.000145	0.00049	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—sarcoma	0.000144	0.000487	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000144	0.0145	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000144	0.0145	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—sarcoma	0.000143	0.000485	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—sarcoma	0.000143	0.000484	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—sarcoma	0.000143	0.000484	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000143	0.0144	CbGpPWpGaD
Clofarabine—Anxiety—Doxorubicin—sarcoma	0.000143	0.000482	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000142	0.000481	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—sarcoma	0.000141	0.000478	CcSEcCtD
Clofarabine—Hypotension—Epirubicin—sarcoma	0.000138	0.000469	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—sarcoma	0.000137	0.000464	CcSEcCtD
Clofarabine—Infection—Doxorubicin—sarcoma	0.000136	0.000461	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000136	0.0137	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000135	0.000457	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—sarcoma	0.000134	0.000455	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—sarcoma	0.000134	0.000454	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—sarcoma	0.000134	0.000453	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000134	0.0135	CbGpPWpGaD
Clofarabine—Skin disorder—Doxorubicin—sarcoma	0.000133	0.000451	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—sarcoma	0.000133	0.00045	CcSEcCtD
Clofarabine—Hyperhidrosis—Doxorubicin—sarcoma	0.000133	0.000449	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—MYC—sarcoma	0.000133	0.0134	CbGpPWpGaD
Clofarabine—Dyspnoea—Epirubicin—sarcoma	0.000132	0.000447	CcSEcCtD
Clofarabine—Somnolence—Epirubicin—sarcoma	0.000132	0.000446	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000132	0.0133	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—sarcoma	0.000131	0.000442	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—STAG1—sarcoma	0.00013	0.0132	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—sarcoma	0.000129	0.000436	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—sarcoma	0.000128	0.000434	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000128	0.000433	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—sarcoma	0.000128	0.000432	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000127	0.0128	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—sarcoma	0.000127	0.000429	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000125	0.000423	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—sarcoma	0.000123	0.000417	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—sarcoma	0.000122	0.000414	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—sarcoma	0.000122	0.000413	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—sarcoma	0.000122	0.000413	CcSEcCtD
Clofarabine—Gastrointestinal pain—Epirubicin—sarcoma	0.000121	0.00041	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—STAG1—sarcoma	0.000119	0.012	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—sarcoma	0.000119	0.000403	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000118	0.000401	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—sarcoma	0.000118	0.0004	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000118	0.0119	CbGpPWpGaD
Clofarabine—Pain—Doxorubicin—sarcoma	0.000117	0.000397	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—sarcoma	0.000117	0.000397	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—sarcoma	0.000117	0.000397	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—STAG1—sarcoma	0.000117	0.0118	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000115	0.0116	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—sarcoma	0.000113	0.000382	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000112	0.00038	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.00011	0.0112	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—sarcoma	0.000109	0.00037	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—MYC—sarcoma	0.000109	0.011	CbGpPWpGaD
Clofarabine—Body temperature increased—Doxorubicin—sarcoma	0.000108	0.000367	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—sarcoma	0.000108	0.000367	CcSEcCtD
Clofarabine—Asthenia—Epirubicin—sarcoma	0.000106	0.00036	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000106	0.0107	CbGpPWpGaD
Clofarabine—Pruritus—Epirubicin—sarcoma	0.000105	0.000355	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000102	0.0103	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—sarcoma	0.000101	0.000343	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—sarcoma	0.000101	0.000342	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—NPM1—sarcoma	0.0001	0.0101	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—sarcoma	9.84e-05	0.000333	CcSEcCtD
Clofarabine—Dizziness—Epirubicin—sarcoma	9.8e-05	0.000332	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—sarcoma	9.7e-05	0.000328	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—sarcoma	9.48e-05	0.00957	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—sarcoma	9.46e-05	0.00955	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—sarcoma	9.42e-05	0.000319	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—sarcoma	9.38e-05	0.000318	CcSEcCtD
Clofarabine—Rash—Epirubicin—sarcoma	9.34e-05	0.000316	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—sarcoma	9.34e-05	0.000316	CcSEcCtD
Clofarabine—Headache—Epirubicin—sarcoma	9.28e-05	0.000314	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	9.28e-05	0.00937	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—sarcoma	9.07e-05	0.000307	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—STAG1—sarcoma	8.92e-05	0.00901	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—sarcoma	8.86e-05	0.00895	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—sarcoma	8.8e-05	0.000298	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	8.79e-05	0.00887	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—sarcoma	8.72e-05	0.000295	CcSEcCtD
Clofarabine—Rash—Doxorubicin—sarcoma	8.65e-05	0.000293	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—sarcoma	8.64e-05	0.000292	CcSEcCtD
Clofarabine—Headache—Doxorubicin—sarcoma	8.59e-05	0.000291	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—sarcoma	8.32e-05	0.0084	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	8.17e-05	0.00825	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—sarcoma	8.15e-05	0.000276	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	8.1e-05	0.00818	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	8.09e-05	0.00816	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—STAG1—sarcoma	7.98e-05	0.00805	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—sarcoma	7.92e-05	0.00799	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—sarcoma	7.79e-05	0.00786	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	7.65e-05	0.00773	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	7.65e-05	0.00772	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	7.64e-05	0.00771	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	7.58e-05	0.00765	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—sarcoma	7.46e-05	0.00753	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—sarcoma	7.28e-05	0.00735	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.85e-05	0.00692	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—NPM1—sarcoma	6.84e-05	0.00691	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—sarcoma	6.67e-05	0.00674	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	6.67e-05	0.00674	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—sarcoma	6.49e-05	0.00655	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	6.32e-05	0.00639	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	6.14e-05	0.0062	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—sarcoma	6.13e-05	0.00619	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	6e-05	0.00606	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	5.98e-05	0.00604	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—sarcoma	5.69e-05	0.00574	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5.67e-05	0.00573	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	5.61e-05	0.00567	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	5.5e-05	0.00556	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—sarcoma	5.42e-05	0.00547	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—sarcoma	5.33e-05	0.00538	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	5.04e-05	0.00509	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	4.95e-05	0.005	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—sarcoma	4.92e-05	0.00496	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.81e-05	0.00485	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—sarcoma	4.56e-05	0.00461	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ENO2—sarcoma	4.52e-05	0.00457	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HBA1—sarcoma	4.49e-05	0.00454	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	4.31e-05	0.00435	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	4.3e-05	0.00434	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	4.27e-05	0.00431	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.86e-05	0.0039	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLCG1—sarcoma	3.84e-05	0.00387	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.76e-05	0.00379	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ENO2—sarcoma	3.72e-05	0.00376	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HBA1—sarcoma	3.7e-05	0.00374	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ENO2—sarcoma	3.48e-05	0.00351	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HBA1—sarcoma	3.46e-05	0.00349	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.46e-05	0.00349	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.38e-05	0.00341	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	3.19e-05	0.00323	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLCG1—sarcoma	3.16e-05	0.00319	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—sarcoma	3.13e-05	0.00316	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—sarcoma	3.05e-05	0.00308	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLCG1—sarcoma	2.95e-05	0.00298	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.84e-05	0.00287	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—sarcoma	2.73e-05	0.00275	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—sarcoma	2.45e-05	0.00247	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—sarcoma	2.19e-05	0.00221	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—sarcoma	2.14e-05	0.00216	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—sarcoma	2.09e-05	0.00211	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—sarcoma	1.87e-05	0.00188	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—sarcoma	1.8e-05	0.00181	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—sarcoma	1.67e-05	0.00169	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—sarcoma	1.5e-05	0.00151	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO2—sarcoma	1.39e-05	0.00141	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HBA1—sarcoma	1.38e-05	0.0014	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—sarcoma	1.23e-05	0.00124	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLCG1—sarcoma	1.18e-05	0.00119	CbGpPWpGaD
